Thomas Meth - 31 Jan 2023 Form 4 Insider Report for Enviva Inc.

Reporting relationship: President and CEO, Director
Issuer ticker: N/A
Reported as of: 31 Jan 2023
Net transaction value: -$342,770
SEC form: 4
Accepted by SEC: 02 Feb 2023, 20:03:51 UTC
Prior SEC filing: 31 Jan 2023
Next SEC filing: 28 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Jason E. Paral, as attorney-in-fact for Thomas Meth

Key filing fact

Thomas Meth filed Form 4 for Enviva Inc. on 02 Feb 2023.

Key facts

This page summarizes Thomas Meth's Form 4 filing for Enviva Inc..
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Feb 2023, 20:03.

Change

Previous filing in this sequence was filed on 31 Jan 2023.
Current net transaction value: -$342,770.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVA transaction

Common Stock

Award

Transaction value: $0
Shares: +18,851
Change %: +4.3%
Price: $0.000000
Shares after: 459,818
Date: 31 Jan 2023
Ownership: Direct

EVA transaction

Common Stock

Tax liability

Transaction value: $342,770
Shares: -7,646
Change %: -1.7%
Price: $44.83
Shares after: 452,172
Date: 01 Feb 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EVA transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +24,736
Change %
Price: $0.000000
Shares after: 24,736
Date: 31 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 24,736
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit is the economic equivalent of one share of common stock and includes a tandem grant of a dividend equivalent right entitling the holder to receive an amount in cash equal to the value of any cash dividends paid to the holders of the Issuer's common stock during the period in which the restricted stock unit is outstanding. The restricted stock units will vest on the fourth anniversary of the date of grant as long as the Reporting Person remains continuously employed through such date, and may be settled in either cash or shares of common stock.